Navigation Links
Upcoming trends in hematological malignancies
Date:9/22/2009

Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include chronic lymphocytic leukemia, the role of molecular biomarkers in diffuse large b-cell lymphoma, follicular lymphoma, management of multiple myeloma and immunomodulation and hematopoietic stem cell transplant.

Featured Speakers:

  • Andre Goy, M.D. Deputy Director, John Theurer Cancer Center, Chief, Division of Lymphoma; Director, Cancer Research
  • Susan O'Brien, M.D. MD Anderson Cancer Center; Professor, Department of Leukemia, Division of Cancer Medicine
  • Wyndham Wilson, M.D., Ph.D. National Cancer Institute, Chief, Lymphoma Therapeutics, Metabolic Branch, Center for Cancer Research
  • Carol Portlock, M.D. Memorial Sloane-Kettering Cancer Center, Professor of Medicine, Attending Physician of Lymphoma
  • Rafael Fonseca, M.D. Mayo Clinic, Professor of Medicine, Deputy Director of Mayo Clinic Cancer Center
  • Robert J. Soiffer, M.D. Dana Farber Cancer Institute, Harvard Medical Professor of Medicine, Harvard Medical School, Chief Division of Blood Centers

This conference is open to the public, but directed primarily for medical oncologists and hematologists, as well as other healthcare professionals in the oncology field who are interested in the treatment of cancer. The conference will be held from 8 am to 2:30 pm in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. If you're interested in attending please contact David Marisol at 201-996-2515 or marisoldavid@humed.com.


'/>"/>

Contact: David Marisol
marisoldavid@humed.com
201-996-2515
John Theurer Cancer Center
Source:Eurekalert

Page: 1

Related medicine news :

1. John Theurer Cancer Center and Leukemia & Lymphoma Society Highlight Upcoming Trends in Hematological Malignancies
2. DURECT Corporation to Participate in Upcoming Healthcare Conferences
3. West to Present at Two Upcoming Investor Conferences
4. Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural Products Expo East Show in Boston
5. WuXi PharmaTech to Participate in Upcoming Investor Conferences
6. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
7. Immucor to Present at Upcoming Investor Conferences
8. WellPoint Announces Appearance at Upcoming Conference
9. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Genomic Health to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: